David H. Johnson
Impact in
- Oncology top 0.05%
- Lung Cancer Research Studies
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 150
- Lung Cancer Research Studies 78
- Cancer Treatment and Pharmacology 28
- Peptidase Inhibition and Analysis 20
- Colorectal Cancer Treatments and Studies 15
-
- Lung Cancer Treatments and Mutations 52
- Lung Cancer Diagnosis and Treatment 16
- Co-authors
- Joan H. SchillerJulie R. BrahmerMichael C. PerryAlan SandlerRobert J. GrayAfshin DowlatiRogério LilenbaumF. Anthony Greco
- Journals
- Journal of Clinical Oncology (37 papers)Lung Cancer (15 papers)Journal of Thoracic Oncology (14 papers)Cancer (10 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David H. Johnson
232 papers receiving 19.6k citations
Hit Papers
Peers
Comparison fields: 5 of 185
- Oncology 14.3k
- Pulmonary and Respiratory Medicine 9.3k
- Epidemiology 4.3k
- Cancer Research 1.8k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by David H. Johnson
This map shows the geographic impact of David H. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Johnson more than expected).
Fields of papers citing papers by David H. Johnson
This network shows the impact of papers produced by David H. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Johnson. The network helps show where David H. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside David H. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 18 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 3 | |
| 6 | 2017 | 4 | |
| 7 | 2016 | 24 | |
| 8 | 2011 | 0 | |
| 9 | 2011 | 1 | |
| 10 | Outcome of Merkel cell carcinoma in renal transplant recipients | 2010 | 1 |
| 11 | 2008 | 0 | |
| 12 | 2007 | 251 | |
| 13 | 2002 | 6 | |
| 14 | Sharing Data: It’s Time to End Psychology’s Guild Approach | 2001 | 7 |
| 15 | 1999 | 13 | |
| 16 | Taxanes in lung cancer therapy | 1998 | 0 |
| 17 | Ifosfamide in non-small cell lung cancer. | 1996 | 16 |
| 18 | Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial. | 1992 | 5 |
| 19 | 1992 | 406 | |
| 20 | 1990 | 150 |
About David H. Johnson
David H. Johnson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Cancer Research and Family Practice, having authored 241 papers that have together received 20.2k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (78 papers), Lung Cancer Treatments and Mutations (52 papers), Neuroendocrine Tumor Research Advances (52 papers), Cancer therapeutics and mechanisms (30 papers), Cancer Treatment and Pharmacology (28 papers), Peptidase Inhibition and Analysis (20 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Colorectal Cancer Treatments and Studies (15 papers). The work is most often cited by research in Oncology (14.3k citations), Pulmonary and Respiratory Medicine (9.3k citations), Epidemiology (4.3k citations), Cancer Research (1.8k citations) and Pathology and Forensic Medicine (1.7k citations). David H. Johnson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Joan H. Schiller, Julie R. Brahmer, Michael C. Perry, Alan Sandler, Robert J. Gray, Afshin Dowlati, Rogério Lilenbaum, F. Anthony Greco, John D. Hainsworth and Henry Wagner. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Journal of Thoracic Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.